ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,936Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 939

$974K Total Retail Price of All Prescriptions

Rank: 49 out of 939

775 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 775 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 775 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 10,223 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,363 409 S3 1 1
OMEPRAZOLE 899 457 2 5
SIMVASTATIN 580 314 3 2
LISINOPRIL 514 293 4 3
METFORMIN HCL 497 265 5 8
LEVOTHYROXINE SODIUM 490 267 6 4
FUROSEMIDE 457 247 7 7
GABAPENTIN 457 151 7 11
AMLODIPINE BESYLATE 401 289 9 6
METOPROLOL TARTRATE 373 205 10 10
CITALOPRAM HBR 355 153 11 15
POTASSIUM CHLORIDE 345 154 12 9
NEXIUM 332 132 13 18
TRAMADOL HCL 320 109 14 16
ZOLPIDEM TARTRATE 319 85 15 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 316 169 16 23
MELOXICAM 312 141 17 14
HYDROCHLOROTHIAZIDE 252 162 18 12
GLIPIZIDE ER 247 133 19 88
TRAZODONE HCL 240 66 20 26
ATENOLOL 239 149 21 19
RANITIDINE HCL 196 79 22 35
WARFARIN SODIUM 196 162 22 17
SERTRALINE HCL 192 111 24 24
GLIPIZIDE 182 140 25 52
CYCLOBENZAPRINE HCL 178 15 R 26 36
ATORVASTATIN CALCIUM 167 104 27 22
ROPINIROLE HCL 162 85 28 78
PROMETHAZINE HCL 159 11 R 29 68
BUSPIRONE HCL 159 37 29 123
ESTRADIOL 149 65 R 31 79
ALLOPURINOL 146 123 32 31
FLUOXETINE HCL 141 37 33 47
NAPROXEN 140 38 34 72
METOPROLOL SUCCINATE 140 79 34 21
PREDNISONE 139 75 36 42
CYMBALTA 137 24 37 44
DICLOFENAC SODIUM 134 76 38 93
TIZANIDINE HCL 133 24 39 81
CLOPIDOGREL 130 76 40 28
TAMSULOSIN HCL 128 78 41 27
CARVEDILOL 123 97 42 25
VENLAFAXINE HCL 122 52 43 159
VENTOLIN HFA 122 36 43 80
AMITRIPTYLINE HCL 120 41 R 45 38
LOSARTAN POTASSIUM 116 109 46 29
LOSARTAN-HYDROCHLOROTHIAZIDE 115 47 47 55
SPIRONOLACTONE 110 43 48 71
METOCLOPRAMIDE HCL 107 35 49 119
ADVAIR DISKUS 106 46 50 60
PROAIR HFA 105 12 51 41
MORPHINE SULFATE ER 104 24 S2 52 113
LYRICA 104 51 52 63
AMOXICILLIN 103 37 54 92
DONEPEZIL HCL 101 78 55 30
CEPHALEXIN 101 34 55 77
BYSTOLIC 100 62 57 132
MIRTAZAPINE 97 48 58 56
CLONIDINE HCL 95 19 59 39
POLYETHYLENE GLYCOL 3350 93 67 60 57
PANTOPRAZOLE SODIUM 92 43 61 66
VERAPAMIL ER 90 65 62 85
PLAVIX 89 51 63 48
BACLOFEN 86 26 64 157
CELEBREX 85 45 65 106
METHOCARBAMOL 85 12 R 65 149
LOVASTATIN 84 75 67 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 32 68 64
PRAVASTATIN SODIUM 82 73 68 13
DILTIAZEM ER 82 75 68 94
DILTIAZEM 24HR CD 78 60 71 126
LANTUS 77 36 72 59
SUCRALFATE 77 32 72 96
ENDOCET 76 17 S2 74 148
FENOFIBRATE 76 31 74 83
OXYCODONE HCL 75 12 S2 76 67
LEVEMIR FLEXPEN 73 42 77 190
OXYBUTYNIN CHLORIDE 72 18 78 125
AZITHROMYCIN 71 33 79 32
KETOCONAZOLE 70 15 80 229
BUMETANIDE 69 43 81 124
DIGOXIN 69 61 81 45
ENALAPRIL MALEATE 68 51 83 65
CARBAMAZEPINE 68 11 83 189
INSULIN SYRINGE 66 41 85 97
NAMENDA 66 66 85 49
CARISOPRODOL 65 0 R 87 51
IBUPROFEN 65 38 87 112
FLUTICASONE PROPIONATE 65 22 87 43
HYDROXYZINE PAMOATE 65 0 R 87 220
SINGULAIR 64 36 91 101
CIPROFLOXACIN HCL 63 29 92 54
ISOSORBIDE MONONITRATE ER 63 49 92 53
DOXYCYCLINE HYCLATE 62 22 94 84
PREMARIN 61 11 R 95 111
KLOR-CON M20 60 41 96 90
PRAMIPEXOLE DIHYDROCHLORIDE 59 34 97 162
PAROXETINE HCL 58 28 98 70
SUMATRIPTAN SUCCINATE 58 0 98 282
COMBIVENT 57 24 100 120
SAVELLA 57 0 100 299
HUMULIN 70-30 57 43 100 200
BENAZEPRIL HCL 57 37 100 87
FENTANYL 56 16 S2 104 104
FAMOTIDINE 56 0 104 62
TESTOSTERONE CYPIONATE 54 44 S3 106 391
DIVALPROEX SODIUM 53 0 107 95
TRIAMTERENE-HCTZ 53 21 107 33
FLUCONAZOLE 51 12 109 140
NORTRIPTYLINE HCL 51 20 109 266
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.